Larson Financial Group’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.86K Buy
132
+59
+81% +$4.25K ﹤0.01% 2415
2026
Q1
$5.2K Buy
73
+20
+38% +$1.37K ﹤0.01% 2591
2025
Q4
$3.14K Buy
53
+26
+96% +$1.41K ﹤0.01% 2648
2025
Q3
$1.49K Buy
27
+8
+42% +$416 ﹤0.01% 2807
2025
Q2
$819 Buy
19
+14
+280% +$540 ﹤0.01% 2711
2025
Q1
$198 Hold
5
﹤0.01% 2799
2024
Q4
$204 Hold
5
﹤0.01% 2436
2024
Q3
$195 Hold
5
﹤0.01% 2381
2024
Q2
$219 Buy
+5
New +$242 ﹤0.01% 2037

Other funds holding NGVT

Larson Financial Group's NGVT Position: Q2 2026 in Review

Larson Financial Group increased its Ingevity (NGVT) stake by 81% in Q2 2026, buying an estimated $4.25K and bringing the position to 132 shares worth $9.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2415.

Larson Financial Group first reported a position in NGVT in Q2 2024 and has held it in 9 quarters since. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • Larson Financial Group held 132 shares of Ingevity worth $9.86K as of Q2 2026.
  • Larson Financial Group bought 59 Ingevity shares in Q2 2026, an estimated $4.25K.
  • Ingevity made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2415 holding.
  • Larson Financial Group first reported a position in Ingevity in Q2 2024 and has held it in 9 quarters since.
  • 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.